Drugs & medicalClass II

Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc.…

Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir…

Read the official notice →
Date
2025-07-23
Country
United States
Brand
Lupin Pharmaceuticals
Product
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD…
Classification
Class II
Units
Product was distributed nationwide within the United States.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Lupin Pharmaceuticals recalls

  1. 2025-12-17
  2. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for:…

    Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

    FDA · DrugLupin Pharmaceuticals Inc.FL, MA, MI & OHOfficial notice →
  3. 2025-08-06
  4. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,…

    Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide in the USOfficial notice →
  5. 2025-07-30
  6. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC#…

    Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide.Official notice →
  7. 2025-04-30
  8. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore,…

    Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.USA nationwideOfficial notice →
  9. 2025-01-08
  10. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,…

    Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.One US distributor in Ohio.Official notice →
  11. 2024-11-27
  12. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02)…

    CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed to 30 wholesalers/distributors who may have further…Official notice →
All 38 Lupin Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2025-07-23
  2. US
    Drugs & medicalClass I

    Baxter Healthcare Corporation recalls Baxter SIGMA Spectrum Infusion Pump V6, Model Number 35700BAX

    Certain Spectrum infusion pumps may have an incorrect version of software.

    FDA · DeviceBaxter Healthcare CorporationUS States: CA, FL, IL, KS, MI, MS, NY, OH, OK, and VA.Official notice →
  3. US
  4. US
    Drugs & medicalClass II

    Ascend Laboratories, LLC recalls Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA,…

    CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.

    FDA · DrugAscend Laboratories, LLCUS Nationwide.Official notice →
  5. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls PERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only,…

    Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.

    FDA · DrugCentral Admixture Pharmacy Services, Inc (CAPS) Los AngelesCAOfficial notice →
  6. US
    Drugs & medicalClass II

    Dr. Reddy's Laboratories, Inc. recalls Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,…

    Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.

    FDA · DrugDr. Reddy's Laboratories, Inc.USA NationwideOfficial notice →
  7. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC…

    Subpotent Drug: Assay below the approved specification

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USAOfficial notice →
See all drugs & medical recalls →